|

Oxaliplatin for injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
  • Shanghai Junshi Bioscience Co., Ltd.1

Indications

  • Cancer2
  • Ovarian Cancer1
  • Intrahepatic Cholangiocarcinoma1

Other2 trials

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
Phase 1/2
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.